Rapid Micro Biosystems (RPID) Gross Profit (2020 - 2026)

Rapid Micro Biosystems has disclosed Gross Profit across 7 years of filings, most recently posting $371000.0 for Q1 2026.

• Gross Profit for Q1 2026 came in at $371000.0, down 8.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.4 million (up 35.48% YoY), and the FY2025 annual result was $21.5 million, up 45.45% from the prior year.
• Gross Profit came in at $371000.0 for Q1 2026 at Rapid Micro Biosystems, down from $8.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $8.0 million in Q4 2025 to a low of $250000.0 in Q4 2022.
• The 5-year median for Gross Profit is $2.3 million (2024), against an average of $2.6 million.
• Across the five-year window, Gross Profit sank 87.5% in 2022 and jumped 1170.4% in 2023, its largest moves.
• Rapid Micro Biosystems' Gross Profit stood at $250000.0 in 2022, then surged by 1170.4% to $3.2 million in 2023, then jumped by 64.86% to $5.2 million in 2024, then soared by 52.02% to $8.0 million in 2025, then plunged by 95.34% to $371000.0 in 2026.
• The last three Gross Profit figures came in at $371000.0 (Q1 2026), $8.0 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.